Article citationsMore>>

Tang, Z., Wang, Y., Yu, Y., Cui, Y., Liang, L., Xu, C., et al. (2022) Neoadjuvant Apatinib Combined with Oxaliplatin and Capecitabine in Patients with Locally Advanced Adenocarcinoma of Stomach or Gastroesophageal Junction: A Single-Arm, Open-Label, Phase 2 Trial. BMC Medicine, 20, Article No. 107.
https://doi.org/10.1186/s12916-022-02309-0

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.